Simulations Plus SLP Stalled Software Forces $375M Exit
SLP surges on $375M take-private buyout — healthcare software stock analysis 👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_podcast&utm_medium=podcast&utm_campaign=freja_and_friends In this deep dive, we break down Simulations Plus, Inc. (SLP) and the pending $375 million take-private acquisition by Altaris, LLC that is reshaping the biosimulation industry. With gross margins expanding to 69% and shares trading at a narrow 0.6% discount to the $18.50 cash offer, the key question for investors is whether…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.